By GINA KOLATA
NYT
A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
Published date: October 9, 2018 at 01:02PM
The New York Times
New York Times article
Няма коментари:
Публикуване на коментар